ArticleThe New England journal of medicine2017
Tobacco-Product Use by Adults and Youths in the United States in 2013 and 2014.
Erratum issued Registry-linked trialAbstract read
In one paragraph
Article in The New England journal of medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04982978 (The Effectiveness of the Protection Motivation Theory in Reducing Vaping Behaviour in a Student Population), which is not on this map. Cited by 430 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
430citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effectiveness of the Protection Motivation Theory in Reducing Vaping Behaviour in a Student Population
Who cites it
430 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Tobacco retailer density and smoking behaviour: how are exposure and outcome measures classified? A systematic review.BMC public health · 2023Pooled it
- The prevalence of electronic cigarettes vaping globally: a systematic review and meta-analysis.Archives of public health = Archives belges de sante publique · 2022Pooled it
- Global Patterns and Prevalence of Dual and Poly-Tobacco Use: A Systematic Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021Pooled it
- Restricting choice of e-cigarette flavor and device type increases choices to use combusted cigarettes among adults who dual use both products: Results from a within-subjects randomized trial.Addictive behaviors · 2026Trial
- Messaging to prevent and reduce young adults' waterpipe tobacco smoking: A randomized trial.Addictive behaviors · 2023Trial
- Responses to pictorial versus text-only cigarillo warnings among a nationally representative sample of US young adults.Tobacco control · 2023Trial
- Effects of Vaping Prevention Messages on Electronic Vapor Product Beliefs, Perceived Harms, and Behavioral Intentions among Young Adults: A Randomized Controlled Trial.International journal of environmental research and public health · 2022Trial
- Visual Attention to Health Warning Labels on Waterpipe Venue Menus in Immersive Virtual Reality.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Trial
- Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022Trial
- Trial
- Testing the Effects of Hookah Tobacco Social Media Risk Communication Messages Among Young Adults.Health education & behavior : the official publication of the Society for Public Health Education · 2021Trial
- Tailored Mobile Messaging Intervention for Waterpipe Tobacco Cessation in Young Adults: A Randomized Trial.American journal of public health · 2021Trial
- Impact of Graphic Warning Messages on Intentions to Use Alternate Tobacco Products.Journal of health communication · 2020Trial
- Applying a mixed-methods approach to evaluate and tailor electronic cigarette pictorial health warning labels for young adults in the United States.BMC public health · 2026Article
- Cigarette and E-Cigarette Use Among Adolescents Based on a Nationwide Survey - China, 2021.China CDC weekly · 2026Article
- Trends in Cigarette Discontinuation Rates in the United States Across 2014/15-2021 Among Adults Who Use Electronic Nicotine Delivery Systems (ENDS): Trends by ENDS Flavor, ENDS Device Type, and Age Group From the PATH Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026Article
- Identifying Latent Classes of Dual Cigarette/ENDS Users Based on Motivations for ENDS Use: Product Substitution Versus Complementary Use.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026Article
- Joinpoint trend analysis of prevalence of combustible and non-combustible tobacco product use by adults in the United States, using cross-sectional data from NHIS 2015-2023.Tobacco induced diseases · 2026Article
- Predictors of cigarette discontinuation and reduction among adults never planning to quit smoking: Longitudinal findings from the U.S. Population Assessment of Tobacco and Health (PATH) study, 2014/15-2021.Tobacco prevention & cessation · 2026Article
- Nicotine: evolution, dependence, and the path to total quit: redefining cessation in a changing nicotine landscape.Frontiers in public health · 2026Review
370 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
22 authors.
Karin A KaszaFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Bridget K AmbroseFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Kevin P ConwayFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Nicolette BorekFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Kristie TaylorFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Maciej L GoniewiczFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
K Michael CummingsFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Eva SharmaFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Jennifer L PearsonFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Victoria R GreenFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Annette R KaufmanFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Maansi Bansal-TraversFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Mark J TraversFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Jonathan KwanFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Cindy TworekFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Yu-Ching ChengFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Ling YangFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Nikolas Pharris-CiurejFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Dana M van BemmelFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Cathy L BackingerFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Wilson M ComptonFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Andrew J HylandFrom the Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY (K.A.K., M.L.G., M.B.-T., M.J.T., A.J.H.); the Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring (B.K.A., N.B., J.K., C.T., Y.-C.C., L.Y., N.P.-C., D.M.B., C.L.B.), National Institute on Drug Abuse (K.P.C., V.R.G., W.M.C.) and Division of Cancer Control and Population Sciences, National Cancer Institute (A.R.K.), National Institutes of Health, Bethesda, and Westat (K.T., E.S.) and Kelly Government Solutions (V.R.G.), Rockville - all in Maryland; the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston (K.M.C.); and the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC (J.L.P.).
Funding
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7MNCI NIH HHS P30 CA138313NIDA NIH HHS HHSN271201100027C
Abstract
backgroundNoncigarette tobacco products are evolving rapidly, with increasing popularity in the United States.
methodsWe present prevalence estimates for 12 types of tobacco products, using data from 45,971 adult and youth participants (≥12 years of age) from Wave 1 (September 2013 through December 2014) of the Population Assessment of Tobacco and Health (PATH) Study, a large, nationally representative, longitudinal study of tobacco use and health in the United States. Participants were asked about their use of cigarettes, e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe tobacco, hookah, snus pouches, other smokeless tobacco, dissolvable tobacco, bidis, and kreteks. Estimates of the prevalence of use for each product were determined according to use category (e.g., current use or use in the previous 30 days) and demographic subgroup, and the prevalence of multiple-product use was explored.
resultsMore than a quarter (27.6%) of adults were current users of at least one type of tobacco product in 2013 and 2014, although the prevalence varied depending on use category. A total of 8.9% of youths had used a tobacco product in the previous 30 days; 1.6% of youths were daily users. Approximately 40% of tobacco users, adults and youths alike, used multiple tobacco products; cigarettes plus e-cigarettes was the most common combination. Young adults (18 to 24 years of age), male adults and youths, members of racial minorities, and members of sexual minorities generally had higher use of tobacco than their counterparts.
conclusionsDuring this study, 28% of U.S. adults were current users of tobacco, and 9% of youths had used tobacco in the previous 30 days. Use of multiple products was common among tobacco users. These findings will serve as baseline data to examine between-person differences and within-person changes over time in the use of tobacco products. (Funded by the National Institute on Drug Abuse and the Food and Drug Administration.).
Indexed as
AdolescentAdultAgedChildElectronic Nicotine Delivery SystemsFemaleHumansMaleMiddle AgedPrevalenceSmokingTobacco ProductsUnited StatesYoung Adult
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT04982978ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.